Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma

Cancer Science

Volumn 97, Issue 6, 2006, Pages 499-504

  Fukuhara, Noriko ^a,b   Tagawa, Hiroyuki ^a   Kameoka, Yoshihiro ^a   Kasugai, Yumiko ^a   Karnan, Sivasundaram ^a   Kameoka, Junichi ^b   Sasaki, Takeshi ^b   Morishima, Yasuo ^a   Nakamura, Shigeo ^c   Seto, Masao ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR REL;

AMPLICON; ARTICLE; B CELL LYMPHOMA; BACTERIAL ARTIFICIAL CHROMOSOME; CARCINOGENESIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORRELATION FUNCTION; GENE AMPLIFICATION; GENE EXPRESSION; GENE FUNCTION; GENETIC GAIN; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 2; GENE AMPLIFICATION; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; NUCLEIC ACID HYBRIDIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33744518094     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00209.x     Document Type: Article

References (30)

1. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group Classification of non-hodgkin's lymphoma. Blood 1997; 89: 3909-18.
2. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
3. Offit K, Le Coco F, Louie DC et al. Rearrangement of BCL6 gene as a prognostic marker in diffuse large cell lymphoma. N Engl J Med 1994; 331: 74-80.
4. Kramer MHH, Hermans J, Wijburg E et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood 1998; 92: 3152-62.
5. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Washington: IARC Press, Lyon, 2001; 171-4.
6. Tagawa H, Tsuzuki S, Suzuki R et al. Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: Comparison between CD5-positive and CD5-negative cases. Cancer Res 2004; 64: 5948-55.
7. Tagawa H, Suguro M, Tsuzuki S et al. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma. Blood 2005; 106: 1770-7.
8. Ota A, Tagawa H, Karnan S et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 2004; 64: 3087-95.
9. Houldsworth J, Mathew S, Rao PH et al. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood 1996; 87: 25-9.
10. Rao PH, Houldsworth J, Dyomina K et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 1998; 92: 234-40.
11. Palanisamy N, Abou-Elella AA, Chaganti SR et al. Similar patterns of genomic alterations characterize primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma. Genes Chromosomes Cancer 2002; 33: 114-22.
12. Bea S, Colomo L, Lopez-Guillermo A et al. Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas. J Clin Oncol 2004; 22: 3498-506.
13. Houldsworth J, Olshen AB, Cattoretti G et al. Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas. Blood 2004; 103: 1862-8.
14. Feuerhake F, Kutok JL, Monti S et al. NFκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes Blood 2005 106 1392-9.
15. Bea S, Zettl A, Wright G et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene expression-based survival prediction. Blood 2005; 106: 3183-90.
16. Martin-Subero JI, Gesk S, Harder L et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 2002; 99: 1474-7.
17. Joos S, Menz CK, Wrobel G et al. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 2002; 99: 1381-7.
18. Goff LK, Neal MJ, Crawley CR et al. The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma. Br J Haematol 2000; 111: 618-25.
19. Pinkel D, Segraves R, Sudar D et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998; 20: 207-11.
20. Telenius H, Carter NP, Bebb CE et al. Degenerate oligonucleotide-primed PCR: General amplification of target DNA by a single degenerate primer. Genomics 1992; 13: 718-25.
21. Kameoka Y, Tagawa H, Tsuzuki S et al. Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B cell lymphoma. Oncogene 2004; 23: 9148-54.
22. Kasugai Y, Tagawa H, Kameoka Y, Morishima Y, Nakamura S, Seto M. Identification of CCND3 and BYSL as candidate targets for 6p21 amplification in diffuse large B-cell lymphoma. Clin Cancer Res 2005; 11: 8265-72.
23. Kubonishi I, Niiya K, Miyoshi I. Establishment of a new human lymphoma line that secretes plasminogen activator. Jpn J Cancer Res 1985; 76: 12-15.
24. Schaadt M, Fonatsch C, Kirchner H, Diehl V. Establishment of a malignant, Epstein-Barr virus (EBV)-negative cell-line from the pleura effusion of a patient with Hodgkin's disease. Blut 1979; 38: 185-90.
25. Nacheva E, Dyer MJ, Metivier C et al. B-cell non-Hodgkin's lymphoma cell line (Karpas 1106) with complex translocation involving 18q21.3 but lacking BCL2 rearrangement and expression. Blood 1994; 84: 3422-8.
26. Takizawa J, Suzuki R, Kuroda H et al. Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia. Jpn J Cancer Res 1998; 89: 712-18.
27. Suguro-Katayama M, Suzuki R, Kasugai Y et al. Heterogeneous copy numbers of API2-MALT1 chimeric transcripts in mucosa-associated lymphoid tissue lymphoma. Leukemia 2003; 17: 2508-12.
28. Joos S, Granzow M, Holtgreve-Grez H et al. Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2. Int J Cancer 2003; 103: 489-95.
29. Joos S, Otano-Joos MI, Ziegler S et al. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996; 87: 1571-8.
30. Satterwhite E, Sonoki T, Willis TG et al. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 2001; 98: 3413-20.